Tag: sodium phenylbutyrate-taurursodial

1. Sodium phenylbutyrate-taurursodiol slowed the functional decline in patients with amyotrophic lateral sclerosis. 2. The mean rate of change for slow vital capacity and plasma phosphorylated axonal neurofilament H subunit were not significantly different between the treatment and control groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Amyotrophic lateral sclerosis (ALS) causes...
1. Sodium phenylbutyrate-taurursodial slowed the functional decline in patients with amyotrophic lateral sclerosis. 2. The mean rate of change for slow vital capacity and plasma phosphorylated axonal neurofilament H subunit were not significantly different between the treatment and control groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Amyotrophic lateral sclerosis (ALS) causes...